Effect of telbivudine on Th17 cells and related cytokines to decrease the viral load and liver dysfunction in chronic hepatitis B patients.
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2016
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 06 Jan 2016 Status changed from not stated to completed.
- 04 Dec 2015 New trial record